Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-27

FDA Approved: PREZCOBIX — Supplemental Application (Janssen Products, LP)

View source ↗

Summary

The FDA approved a supplemental application for PREZCOBIX (darunavir ethanolate and cobicistat) from Janssen Products, LP.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREZCOBIX (darunavir ethanolate and cobicistat)

Snippet

SUPPL AP for PREZCOBIX (DARUNAVIR ETHANOLATE AND COBICISTAT)